613 related articles for article (PubMed ID: 22466477)
1. Inhibitory activity of ranibizumab, sorafenib, and pazopanib on light-induced overexpression of platelet-derived growth factor and vascular endothelial growth factor A and the vascular endothelial growth factor A receptors 1 and 2 and neuropilin 1 and 2.
Kernt M; Thiele S; Neubauer AS; Koenig S; Hirneiss C; Haritoglou C; Ulbig MW; Kampik A
Retina; 2012 Sep; 32(8):1652-63. PubMed ID: 22466477
[TBL] [Abstract][Full Text] [Related]
2. Sorafenib prevents human retinal pigment epithelium cells from light-induced overexpression of VEGF, PDGF and PlGF.
Kernt M; Neubauer AS; Liegl RG; Hirneiss C; Alge CS; Wolf A; Ulbig MW; Kampik A
Br J Ophthalmol; 2010 Nov; 94(11):1533-9. PubMed ID: 20962354
[TBL] [Abstract][Full Text] [Related]
3. Expression and regulation of vascular endothelial growth factor ligands and receptors during menstruation and post-menstrual repair of human endometrium.
Punyadeera C; Thijssen VL; Tchaikovski S; Kamps R; Delvoux B; Dunselman GA; de Goeij AF; Griffioen AW; Groothuis PG
Mol Hum Reprod; 2006 Jun; 12(6):367-75. PubMed ID: 16648151
[TBL] [Abstract][Full Text] [Related]
4. Intra-amniotic infection upregulates decidual cell vascular endothelial growth factor (VEGF) and neuropilin-1 and -2 expression: implications for infection-related preterm birth.
Snegovskikh VV; Schatz F; Arcuri F; Toti P; Kayisli UA; Murk W; Guoyang Luo ; Lockwood CJ; Norwitz ER
Reprod Sci; 2009 Aug; 16(8):767-80. PubMed ID: 19474288
[TBL] [Abstract][Full Text] [Related]
5. [Cytoprotective and antiangiogenic effects of the multikinase inhibitor sorafenib on human retinal pigmentepithelium].
Kernt M; Thiele S; Hirneiss C; Neubauer AS; Lackerbauer CA; Wolf A; Eibl KH; Haritoglou C; Ulbig MW; Kampik A
Ophthalmologe; 2011 May; 108(5):445-51. PubMed ID: 21253747
[TBL] [Abstract][Full Text] [Related]
6. Sorafenib protects human optic nerve head astrocytes from light-induced overexpression of vascular endothelial growth factor, platelet-derived growth factor, and placenta growth factor.
Kernt M; Liegl RG; Rueping J; Neubauer AS; Haritoglou C; Lackerbauer CA; Eibl KH; Ulbig MW; Kampik A
Growth Factors; 2010 Jun; 28(3):211-20. PubMed ID: 20166888
[TBL] [Abstract][Full Text] [Related]
7. Immunolocalization and expression of vascular endothelial growth factor receptors (VEGFRs) and neuropilins (NRPs) on keratinocytes in human epidermis.
Man XY; Yang XH; Cai SQ; Yao YG; Zheng M
Mol Med; 2006; 12(7-8):127-36. PubMed ID: 17088944
[TBL] [Abstract][Full Text] [Related]
8. Axitinib modulates hypoxia-induced blood-retina barrier permeability and expression of growth factors.
Kernt M; Thiele S; Liegl RG; Kernt B; Eibl K; Haritoglou C; Ulbig MW; Kampik A
Growth Factors; 2012 Feb; 30(1):49-61. PubMed ID: 22168366
[TBL] [Abstract][Full Text] [Related]
9. Intracranial meningiomas, the VEGF-A pathway, and peritumoral brain oedema.
Nassehi D
Dan Med J; 2013 Apr; 60(4):B4626. PubMed ID: 23651727
[TBL] [Abstract][Full Text] [Related]
10. [Advances of research on vascular endothelial growth factor receptors in epidermal neoplasm].
YANG P; ZHENG M
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2009 Jul; 38(4):422-6. PubMed ID: 19693983
[TBL] [Abstract][Full Text] [Related]
11. Influence of ranibizumab on vascular endothelial growth factor plasma level and endothelial progenitor cell mobilization in age-related macular degeneration patients: safety of intravitreal treatment for vascular homeostasis.
Machalińska A; Paczkowska E; Pabin T; Safranow K; Karczewicz D; Machaliński B
J Ocul Pharmacol Ther; 2011 Oct; 27(5):471-5. PubMed ID: 21830945
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor as an autocrine survival factor for retinal pigment epithelial cells under oxidative stress via the VEGF-R2/PI3K/Akt.
Byeon SH; Lee SC; Choi SH; Lee HK; Lee JH; Chu YK; Kwon OW
Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):1190-7. PubMed ID: 19834034
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of VEGF-receptors (FLT-1, KDR, NRP-1) and thrombospondin-1 is associated with glomeruloid microvascular proliferation, an aggressive angiogenic phenotype, in malignant melanoma.
Straume O; Akslen LA
Angiogenesis; 2003; 6(4):295-301. PubMed ID: 15166498
[TBL] [Abstract][Full Text] [Related]
14. Effects of thrombin on RPE cells are mediated by transactivation of growth factor receptors.
Hollborn M; Petto C; Steffen A; Trettner S; Bendig A; Wiedemann P; Bringmann A; Kohen L
Invest Ophthalmol Vis Sci; 2009 Sep; 50(9):4452-9. PubMed ID: 19369239
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of vascular endothelial growth factor implies the limbal origin of pterygia.
Gebhardt M; Mentlein R; Schaudig U; Pufe T; Recker K; Nölle B; Al-Samir K; Geerling G; Paulsen FP
Ophthalmology; 2005 Jun; 112(6):1023-30. PubMed ID: 15885787
[TBL] [Abstract][Full Text] [Related]
16. VEGF receptors are differentially expressed by neuroblastoma cells in culture.
Beierle EA; Dai W; Langham MR; Copeland EM; Chen MK
J Pediatr Surg; 2003 Mar; 38(3):514-21. PubMed ID: 12632379
[TBL] [Abstract][Full Text] [Related]
17. Anti-angiogenic effects of the receptor tyrosine kinase inhibitor, pazopanib, on choroidal neovascularization in rats.
Yafai Y; Yang XM; Niemeyer M; Nishiwaki A; Lange J; Wiedemann P; King AG; Yasukawa T; Eichler W
Eur J Pharmacol; 2011 Sep; 666(1-3):12-8. PubMed ID: 21620822
[TBL] [Abstract][Full Text] [Related]
18. Suppression of VEGF-mediated autocrine and paracrine interactions between prostate cancer cells and vascular endothelial cells by soy isoflavones.
Guo Y; Wang S; Hoot DR; Clinton SK
J Nutr Biochem; 2007 Jun; 18(6):408-17. PubMed ID: 17142033
[TBL] [Abstract][Full Text] [Related]
19. Expression of VEGF and angiopoietins in subfoveal membranes from patients with age-related macular degeneration.
Hera R; Keramidas M; Peoc'h M; Mouillon M; Romanet JP; Feige JJ
Am J Ophthalmol; 2005 Apr; 139(4):589-96. PubMed ID: 15808152
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of vascular endothelial growth factor A, its receptors VEGFR-1, -2, and -3 and co-receptors neuropilin-1 and -2 does not predict bevacizumab response in human astrocytomas.
Baumgarten P; Blank AE; Franz K; Hattingen E; Dunst M; Zeiner P; Hoffmann K; Bähr O; Mäder L; Goeppert B; Machein M; Seifert V; Steinbach JP; Plate KH; Harter PN; Mittelbronn M
Neuro Oncol; 2016 Feb; 18(2):173-83. PubMed ID: 26627848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
